ALIZF (Allianz SE) Research & Development: $0 Mil (TTM As of Mar. 2026)


ALIZF Allianz SE ALIZF
80 GF Score
Price $454.13
GF Value $394.23
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Allianz SE Research & Development?

Allianz SE ALIZF 80 Research & Development is $0 Mil as of Mar. 2026. GuruFocus rates ALIZF with a GF Score™ of 80/100 and a GF Value™ of $394.23 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Allianz SE's Research & Development for the three months ended in Mar. 2026 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0 Mil.

Allianz SE  (OTCPK:ALIZF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Allianz SE Research & Development Related Terms

Allianz SE Research & Development Historical Data

* Premium members only.

The historical data trend for Allianz SE's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allianz SE Research & Development Chart

Allianz SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Allianz SE Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ALIZF
80GF Score
Allianz SE ALIZF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Allianz SE Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0 Mil mean?
Allianz SE (ALIZF) has a Research & Development of $0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Allianz SE and its competitors.
Is Allianz SE's Research & Development too high?
Allianz SE's current Research & Development is $0 Mil. Overall, Allianz SE has a GF Score™ of 80/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Allianz SE's Research & Development compare to BRK.A and AIG?
Allianz SE's Research & Development of $0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Allianz SE and its competitors. Allianz SE's current Research & Development is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allianz SE stock overvalued right now?
Based on GuruFocus' analysis, Allianz SE (ALIZF) is currently considered Modestly Overvalued. The stock's GF Value™ is $394.23, compared to a current price of $454.13 — trading 15.2% above its estimated fair value. The current Research & Development is $0 Mil. Allianz SE's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Allianz SE (ALIZF), the current Research & Development is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allianz SE (ALIZF) Overvalued in 2026?

Based on GuruFocus' analysis, Allianz SE stock appears to be overvalued. The current stock price of $454.13 is trading 15.2% above its estimated GF Value™ of $394.23. GuruFocus considers Allianz SE to be Modestly Overvalued.

Key valuation signals for ALIZF:

  • Research & Development: $0 Mil
  • GF Value™: $394.23 vs. price of $454.13 (15.2% above fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the ALIZF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Allianz SE Business Description

Address Koniginstrasse 28, Munich, BY, DEU, 80802
Allianz was founded as a transport and accident insurance firm in 1890 by Carl von Thieme and Wilhelm von Finck, the founders of Munich Re. It took the company five years to expand into Europe and North America and subsequently list in Berlin. After World War I, individuals were confronted with the loss of wealth, life, and security and Allianz founded a life business in the 1920s. In the years after World War II, Allianz's foreign assets were seized, and it lost its foreign business. By relocating its head office from Berlin to Munich in 1948, Allianz began the long road of rebuilding its domestic business. It took 20 years for the company to reacquire its prior foreign interests, starting in Austria. It became the largest European insurer in the postwar boom era.
80GF Score

Get the complete analysis for ALIZF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$454.13
Price
$394.23
GF Value